Skip to main content
TipRanks
Go Ultimate75% OFF

Rohto Pharmaceutical Co (RPHCF) Stock Forecast & Price Target

3 Followers
See the Price Targets and Ratings of:

RPHCF Analyst Ratings

Moderate Buy
2Ratings
1Buy1Hold0Sell
Based on 2 analysts giving stock ratings to Rohto Pharmaceutical Co in the past 3 months

RPHCF Stock 12 Month Forecast

$21.21▲(28.65% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Rohto Pharmaceutical Co in the last 3 months. The average price target is $21.21 with a high forecast of $21.21 and a low forecast of $21.21. The average price target represents a 28.65% change from the last price of $16.49.
Highest Price Target$21.21Average Price Target$21.21Lowest Price Target$21.21

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for RPHCF
Price TargetArticle
Jefferies$21.21buy28.65%UpsideReiterated10/21/26
Goldman Sachs Analyst forecast on RPHCFUnknown AnalystNot RankedGoldman Sachs―hold―Reiterated09/24/26
UBS Analyst forecast on RPHCFUnknown AnalystNot RankedUBS$16.46hold-0.15%DownsideInitiated12/12/25
Stocks with the Highest Top Analyst Consensus in the Consumer Defensive Sector
PFGCPerformance Food Group
PREPrenetics Group
JBSJBS
MAMAMama's Creations
WMTWalmart

Find stocks in the Consumer Defensive sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Rohto Pharmaceutical Co

3 Months
Success Rate3/7 ratings generated profit
43%
Average Return
+2.24%

Copying Hisae Kawamoto's trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of +2.24% per trade.

1 Year
Success Rate3/7 ratings generated profit
43%
Average Return
-0.41%

Copying Hisae Kawamoto's trades and holding each position for 1 Year would result in 42.86% of your transactions generating a profit, with an average return of -0.41% per trade.

2 Years
Success Rate3/7 ratings generated profit
43%
Average Return
-1.69%

Copying Hisae Kawamoto's trades and holding each position for 2 Years would result in 42.86% of your transactions generating a profit, with an average return of -1.69% per trade.

RPHCF Analyst Recommendation Trends

01234Nov 25Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26
Monthly rating counts for RPHCF
RatingJun 26Jul 26Aug 26Sep 26Oct 26
Strong Buy00000
Buy11111
Hold00111
Sell00000
Strong Sell00000
total11222

In the current month, RPHCF has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. RPHCF average Analyst price target in the past 3 months is 21.21.

RPHCF Financial Forecast

$-1$-0.5$0$0.5$1Q3 2025Q1 2026Q2 2026
High$0.23
Consensus$0.20
Low$0.18

RPHCF Earnings Forecast

Next quarter’s earnings estimate for RPHCF is $0.20 with a range of $0.18 to $0.23. The previous quarter’s EPS was $0.30. Its overall industry beat the EPS estimate 38.89% of the time in the past 12 months.

$515.1M$530.1M$545.2M$560.3M$575.4MQ3 2025Q1 2026Q2 2026
High$575M
Consensus$559M
Low$538M

RPHCF Sales Forecast

Next quarter’s sales forecast for RPHCF is $558.96M with a range of $537.93M to $575.35M. The previous quarter’s sales results were $573.46M. Its overall industry beat sales estimates 57.45% of the time in the past 12 months.

RPHCF Stock Forecast FAQ

What is RPHCF’s average 12-month price target, according to analysts?
Based on analyst ratings, Rohto Pharmaceutical Co’s 12-month average price target is $21.21.
What is RPHCF’s upside potential, based on the analysts’ average price target?
Rohto Pharmaceutical Co has 28.65% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is RPHCF a Buy, Sell or Hold?
Rohto Pharmaceutical Co has a consensus rating of Moderate Buy which is based on 1 buy ratings, 1 hold ratings and 0 sell ratings.
What is Rohto Pharmaceutical Co’s price target?
The average price target for Rohto Pharmaceutical Co is $21.21. This is based on 2 12-month price targets, issued in the past 3 months. The highest analyst price target is $21.21, the lowest forecast is $21.21. The average price target represents a 28.65% increase from the current price of $16.485.
What do analysts say about Rohto Pharmaceutical Co?
Rohto Pharmaceutical Co’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of RPHCF?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.